Teratology Society 59th Annual Meeting

Teratology Society 59th Annual Meeting is organized by The Teratology Society and will be held from Jun 22 - 26, 2019 at Sheraton San Diego Hotel & Marina, San Diego, California, United States of America.

Target Audience:
Family Medicine, Medical Genetics and Genomics, Neonatologists, Obstetrics and Gynecology, Ophthalmology, Pediatrics, Urology

Accreditation:
USF Health designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from ACCME accredited providers. Physician Assistants who participate will receive a certificate of completion commensurate with the extent of their participation.

Nurse Practitioners
AANPCP accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from ACCME accredited providers. Nurse Practitioners who participate will receive a certificate of completion commensurate with the extent of their participation.

Course Description:
The theme of the 2019 meeting is “Sea Changes in Birth Defects Research and Prevention” and will cover basic, epidemiologic, and clinical research and the application of new technologies to the understanding and prevention of birth defects, and postnatal/functional effects.

Birth defects and developmentally-mediated disorders constitute a major public health concern in the world today. Human development can be affected by drugs, chemicals, infectious diseases, diet, genetics, and maternal health as well as and socioeconomic factors. Understanding and protecting against potential hazards to developing embryos, fetuses, and children requires advanced scientific knowledge from diverse and novel fields such as cell and molecular biology, developmental biology and toxicology, computational modeling, genetics, and epidemiology. The science is put into practice in the areas of prenatal medicine, pediatrics, obstetrics, neonatology, medical genetics, counseling, product safety, risk assessment, and governmental regulations.

The program offers an exciting variety of scientific sessions on topics including:
• Choline supplementation to prevent neurodevelopment disorders
• Effective strategies to reduce maternal mortality
• Ocean-borne risks to the developing brain
• Establishing confidence in alternative test methods
• Improving thyroid hormone assessments
• Environmental exposures and the developing immune system
• Mechanistic insights from zebrafish
• Integrating animal and human data for drug testing
• Birth defects outcomes across the lifespan
• Differences in sex development
• Innovator award, Trainee awards, Professional development workshops

Course Competencies:
• Medical / Pharmacotherapy Knowledge
• Employ Evidence Based Practice
• Utilize Informatics
• Professionalism
• Systems-based Practice

Learning Objectives:
• Identify at least three health services research methods that can be applied to the study of children and/or adults born with birth defects.
• Describe challenges in assessing the prevalence of congenital heart defects in adult populations.
• Discuss the role and contribution of patient registries for health services research concerning specific birth defects.
• Summarize how research focusing on costs, health care use, and outcomes for individuals with birth defects can enhance our understanding of the impact of birth defects on individuals, families, and society.
• Describe disorders of sex development (DSDs) in male and female newborns and adolescents.
• Characterize evolving options for medical and surgical management decisions that are available to patients with DSDs.
• Discuss the psychological, behavioral, and social challenges related to DSDs.
• Recognize the collaborative role that patients, caregivers, and health care professionals have in developing and implementing a care plan.
• Identify the potential role of xenobiotics, such as endocrine disrupting chemicals, in DSDs and the use of research in animal models to explore the origins of phenotypic differences.
• Recognize different criteria for assessing causality (including the Shepard’s Criteria; Brent’s Criteria; Bradford Hill Criteria).
• Know historical examples of how teratogens were identified (including Fetal Alcohol Spectrum Disorder among others).
• Explain how clinical evidence can assist in the process of teratogen identification.
• Know what a Directed Acyclic Graph is and how they are used to better understand causal relations between a potential teratogen and the birth defects it may cause.
• Describe contributors to the increase in maternal morbidity and mortality in the United States.
• Identify and assess maternal morbidity and mortality risks within their practice and describe how those risks can be reduced.
• Discuss whether Quality Improvement Initiatives could be developed and implemented at the state level.
• Discuss contributors to hypertensive and cardiovascular disorders in pregnancy and the potential impact of hypertensive disorders on maternal morbidity and mortality.

* Payment of the Nonmember registration fee includes 2019 membership dues if a Regular or Associate membership application is received and approved for the July 1 application deadline
**Choose discounted combined registration to attend both sessions.